Papers/PMID:26302914
Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)2015The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
chromium(3+) — decreases glycated haemoglobin (HbA1c)
Evidence strength: very limited.Findingreplicated ×2“Post-treatment HbA1c values in supplemented patients were significantly lower than those of control patients.”
Quoted verbatim from Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.. - Study
- RCT
- Duration
- 4 months
- Dose
- 600 μg/day chromium picolinate for four months
- Population
- Patients with poorly controlled type 2 diabetes (HbA1c above 7%) on prescribed medications and ADA nutritional guidance, supplemented with chromium picolinate versus placebo
Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.2015PMID:2630291410.1016/j.jtemb.2015.05.006Permalink